Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: A novel approach from immune/inflammatory aspect

Japanese Journal of Cancer Research

Volumn 88, Issue 1, 1997, Pages 72-81

  Takeha, Satoshi ^a,b   Fujiyama, Yoshihide ^b   Bamba, Tadao ^b   Sorsa, Timo ^c   Nagura, Hiroshi ^a   Ohtani, Haruo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Colorectal cancer; Host reaction; Liver metastasis; MMP 9; Urokinase receptor

Indexed keywords

COLLAGENASE; GELATINASE B; PLASMINOGEN ACTIVATOR; RECEPTOR; UROKINASE;

ARTICLE; CANCER GROWTH; CANCER IMMUNOLOGY; COLORECTAL CANCER; HOST CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER METASTASIS; LYMPHOCYTIC INFILTRATION; NEUTROPHIL; PRIORITY JOURNAL; STROMA; TUMOR PROMOTION;

EID: 0031057805     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00304.x     Document Type: Article

References (42)

1. van Ravenswaay Claasen, H. H., Kluin, P. M. and Fleuren, G. J. Tumor infiltrating cells in human cancer. Lab. Invest., 67, 166-174 (1992).
2. Pretlow, T. P., Keith, E. F., Cryar, A. K., Bartolucci, A. A., Pretlow II, T. G., Kimball, P. M. and Boohaker, E. A. Eosinophil infiltration of human colonic carcinoma as a prognostic indicator. Cancer Res., 43, 2997-3000 (1983).
3. Fisher, E. R., Paik, S. M., Rockette, H., Jones, J., Caplan, R. and Fisher, B. Prognostic significance of eosinophils and mast cells in rectal cancer. Hum. Pathol., 20, 159-163 (1989).
4. Harrison, J. C., Dean, P. J., El-Zeky, F. and Zwaag, R. V. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer. Hum, Pathol., 26, 31-38 (1995).
5. Jass, J. R., Love, S. B. and Northover, J. M. A. A new prognostic classification of rectal cancer. Lancet, 329, 1303-1306 (1987).
6. Nagai, E., Yao, T., Sakamoto, M., Akazawa, K., Utsunomiya, T. and Tsuneyoshi, M. Risk factors related to liver metastasis in colorectal carcinoma: a multivariate analysis of clinicopathologic and immunohistochemical variables. Jpn. J. Cancer Res., 85, 1280-1287 (1994).
7. Suzuki, Y., Ohtani, H., Mizoi, T., Takeha, S., Shiiba, K., Matsuno, S. and Nagura, H. Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn. J. Cancer Res., 86, 585-593 (1995).
8. Poste, G. and Fidler, I. J. The pathogenesis of cancer metastasis. Nature, 283, 139-146 (1980).
9. Dane, K., Andreasen, P. A., Grohndahl-Hansen, J., Kristensen, P., Nielsen, L. S. and Skrier, L. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res., 44, 139-266 (1985).
10. Tryggvason, K., Höyhtyä, M. and Pyke, C. Type IV collagenases in invasive tumors. Breast Cancer Res. Treat., 24, 209-218 (1993).
11. Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A. Tumor cell interaction with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9, 541-573 (1993).
12. Nakajima, M. and Chop, A. M. Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin. Cancer Biol., 2, 115-127 (1991).
13. Birkedal-Hansen, H. Role of matrix metalloproteinases in human periodontal disease. J. Periodontol., 64, 474-484 (1993).
14. Zucker, S., Lysik, R. M., Zarrabi, M. H. and Moll, U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res., 53, 140-146 (1993).
15. Danø, K., Andreasen, P. A., Grohndahl-Hansen, J., Kristensen, P., Nielsen, L. S. and Skriver, L. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res., 44, 139-266 (1985).
16. Ellis, V., Pyke, C., Eriksen, J., Solberg, H. and Danø, K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann. NY Acad. Sci., 667, 13-31 (1992).
17. Pyke, C., Ralfkiaer, E., Tryggvason, K. and Danø, K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142, 359-365 (1993).
18. Pyke, C., Ralfkiaer, E., Huhtala, P., Hurskainen, T., Danø, K. and Tryggvason, K. Localization of messenger RNA for Mr72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res., 52, 1336-1341 (1992).
19. Nielsen, B. S., Timshel, S., Kjeldsen, L., Sehested, M., Pyke, C., Borregaard, N. and Danø, K. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer, 65, 57-62 (1996).
20. Pyke, C., Ralfkiaer, E., Rønne, E., Hyer-Hansen, G., Kirkeby, L. and Danø, K. Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology, 24, 131-138 (1994).
21. Matovani, A., Bottazzi, B., Colotta, F., Sozzani, S. and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13, 265-270 (1992).
22. Kjeldsen, L., Bjerrum, O. W., Hovgaard, D., Johnsen, A. H., Sehested, M. and Borregaard, N. Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. Eur. J. Haematol., 49, 180-191 (1992).
23. Michaelis, J., Vissers, M. C. and Winterbourn, C. C. Human neutrophil collagenase cleaves alpha 1-antitrypsin. Biochem. J., 270, 809-814 (1990).
24. 2-terminal domain of the urokinase receptor. FEBS Lett., 288, 233-236 (1991).
25. Sorsa, T., Ding, Y., Salo, T., Lauhio, O., Teronen, T., Ingman, H., Ohtani, H., Andoh, N., Takeha, S. and Konttinen, T. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann. NY Acad. Sci., 732, 112-131 (1994).
26. Shin, R.-W., Iwaki, T., Kitamoto, T. and Tateishi, J. Hydrated autoclave pretreatment enhances TAU immuno-reactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab. Invest., 64, 693-701 (1992).
27. Ohtani, H., Pyke, C., Danø, K. and Nagura, H. Expression of urokinase receptor in various stromal cell populations in human colon cancer: immunoelectron microscopical analysis. Int. J. Cancer, 62, 691-696 (1995).
28. Gerrard, T. L., Cohen, D. J. and Kaplan, A. M. Human neutrophil-mediated cytotoxicity to tumor cells. J. Natl Cancer Inst., 66, 483-488 (1981).
29. Hara, I., Hotta, H., Sato, N., Eto, H., Arakawa, S. and Kamidono, S. Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2. Jpn. J. Cancer Res., 87, 724-729 (1996).
30. Lacraz, S., Isler, P., Vey, E., Welgus, H. G. and Dayer, J. H. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol Chem., 269, 22027-22033 (1994).
31. Liabakk, N.-B., Talbot, I., Smith, R. A., Wilkinson, K. and Balkwill, F. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res., 56, 190-196 (1996).
32. Sitrin, R. G., Todd, R. F., Mizukami, I. F., Gross, T. J., Shollenberger, S. B. and Gyetko, M. R. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood, 84, 1268-1275 (1994).
33. Nykjaer, A., Moller, B., Todd, R. F., Christensen, T., Andreasen P. A., Glieman, J. and Petersen, C. M. Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol., 152, 505-516 (1994).
34. Mizoi, T., Ohtani, H., Suzuki, Y., Shiiba, K., Matsuno, S. and Nagura, H. Intercellular adhesion molecule-1 expression by macrophages in human gastrointestinal carcinoma: possible roles in host immune/inflammatory reaction. Pathol. Int., 45, 565-572 (1995).
35. Chaux, P., Moutet, M., Faivre, J., Martin, F. and Martin, M. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab. Invest., 74, 975-983 (1996).
36. Ohtani, H., Kuroiwa, A., Obinata, M., Ooshima, A. and Nagura, H. Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridization and immunoelectron microscopy. J. Histochem. Cytochem., 40, 1139-1146 (1992).
37. Sorsa, T., Lukinmaa, P. L., Westerlund, U., Ingman, T., Ding, Y., Tschesche, H., Konittien, Y., Helaakoski, T. and Salo, T. The expression, activation and chemotherapeutic inhibition of matrix metaIloproteinase-8 (neutrophil col- lagenase/collagenase2) in inflammation. In "The Biological Mechanisms of Tooth Eruption, Resorption and Replacement by Implants," ed. Z. Davidovitch, pp. 1-11 (1996). Harvard Society for the Advancement of Orthodontics, Boston, Massachusetts.
38. Ohtani, H., Nagai, T. and Nagura, H. Similarities of in situ mRNA expression between gelatinase A (MMP-2) and type I procollagen in human gastrointestinal carcinoma: comparison with granulation tissue reaction. Jpn. J. Cancer Res., 86, 833-839 (1995).
39. Gress, T. M., Muller-Pillasch, F., Lerch, M. M., Friess, H., Buhler, M. and Adler, G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer. 62, 407-413 (1995).
40. Swallow, C. J., Murray, M. P. and Guillem, J. G. Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes, Clin. Exp. Metastasis, 14, 3-11 (1996).
41. Ronne, J., Bugge, T. H., Pyke, C., Loud, L. R., Flick, M. J., Degen, J. L. and Danø, K. Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med., 2, 287-292 (1996).
42. Emmert-Buck, M. R., Roth, M. J., Zhuang, Z., Campo, E., Rozhin, J., Sloane, B. F., Liotta, A. and Stetler-Stevenson, W. G. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol., 145, 1285-1290 (1994).